Abstract
DURING an investigation of the uptake of tritiated thymidine by mouse tumour tissue, fortuitous sections of tumour were found showing a large capillary sinusoid cut along its long axis for a distance of 2,000µ. Autoradiographs of these sections showed concentric zones of labelled cells, unlabelled cells morphologically intact, and necrotic tumour cells, at increasing distances from the capillary.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Mendelsohn, M. D., Science, 135, 213 (1962).
Thomlinson, R. H., Brit. J. Cancer, 14, 555 (1960).
Johnson, H. A., and Bond, V. P., Cancer, 14, 639 (1961).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
KLIGERMAN, M., HEIDENREICH, W. & GREENE, S. Distribution of Tritiated Thymidine about a Capillary Sinusoid in a Transplanted Mouse Tumour. Nature 196, 282–283 (1962). https://doi.org/10.1038/196282a0
Issue Date:
DOI: https://doi.org/10.1038/196282a0
This article is cited by
-
Prognostic significance of the bromodeoxyuridine labeling index in primary colorectal carcinoma
Surgery Today (1997)
-
In situ analysis of cell kinetics in human brain tumors
Acta Neuropathologica (1989)
-
The relation between tumor cell proliferation and vascularization in differentiated and undifferentiated colon carcinomas in the rat
Virchows Archiv B Cell Pathology Including Molecular Pathology (1982)
-
Kinetics of cell proliferation and cell loss in the peripheral and central parts of walker tumours growing in rats and nude mice
Virchows Archiv B Cell Pathology (1975)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.